The 6th China Health and Senior Care Conference held in southwest Chinese city Shizhu
CHONGQING, China, Sept. 21, 2022 /PRNewswire/ -- On August 30th, the 6th China Health and Senior Care Conference was held in Huangshui Town, a summer resort in Shizhu Tujia Autonomous County, southwest China's Chongqing Municipality. Hosted by the Revolutionary Committee of the Chinese Kuomintang and the Chongqing Municipal Political Consultative Conference, the conference sought to promote the development of...
Mediaseek’s Proprietary Neurofeedback Engine “Alpha Switch” and Its Smartphone Application Mentioned in International Journal
- Engine and App Used in Research Paper on Chronic Low Back Pain Treatment at Pain Center of Chiba University Hospital Published in "Scientific Reports" - TOKYO, Sept. 21, 2022 /PRNewswire/ -- Mediaseek, Inc. (hereinafter referred to as "Mediaseek") based in Tokyo is pleased to announce that a research article on the treatment of nonspecific chronic low back pain, conducted by the...
Love Your Heart event to offer tips on overall and heart health
SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Farrer Park Hospital (FPH) will hold a health awareness event on Saturday, 24 September at Pek Kio Community Centre. Marking World Heart Day which falls on 29 September, the Love Your Heart event aims to draw awareness of the link between overall and heart health. Participants can...
Excelra partners with Patcore, Inc.
The partnership expands Excelra's scientific products footprint in the Japanese market HYDERABAD, India and TOKYO, Sept. 21, 2022 /PRNewswire/ -- Excelra today announced a partnership with Patcore, Inc., providing greater access to Excelra's scientific data and analytics products for customers in Japan. Excelra is one of the leading global data and digital insights...
SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore
SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd (SCG), has announced today the establishment of a state-of-the-art cell therapy research and manufacturing hub in Singapore. With the support of the Singapore Economic Development Board (EDB), the hub comprises a pilot manufacturing facility and an R&D centre. SCG expects to begin...
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data
MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L- iodo-phenylalanine, or 131I-IPA) in combination with external beam radiation therapy (EBRT) in recurrent glioblastoma multiforme (GBM). The primary objective of the IPAX-1 study was...
Amare Global Announces Acquisition of Kyäni, Inc.
Amare Continues Momentum and Expands Global Footprint with Strategic Partnership SALT LAKE CITY, Sept. 21, 2022 /PRNewswire/ -- Amare Global, The Mental Wellness Company, announced today the acquisition of Kyäni, Inc., a globally recognized and respected pioneer in health and wellness with business operations in over 50 countries. Through this acquisition, Amare begins a...
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming
PALO ALTO, Calif., Sept. 21, 2022 /PRNewswire/ -- Koji Tanabe of I Peace, Inc. (https://www.ipeace.com) and a researcher Hiroko Nobuta of the University of California, San Francisco (currently assistant professor at Rutgers University) successfully achieved the direct reprogramming: the direct and rapid transformation of Dermal fibroblasts into Oligodendrocyte precursor cells by inducing...
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
GAITHERSBURG, Md. and SUZHOU, China, Sept. 20, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments on delivery of novel RNAi therapies for cancer, and its GalAhead™ platform and programs, at the 2nd Annual Oligonucleotide Therapeutics and...
Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH)
SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, today released the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on Transcatheter Cardiovascular Therapy conference (TCT 2022),one of the world's most influential cardiovascular conference. PADN is an innovative radiofrequency ablation technique in treating PH, was recognized as a CFDA innovative medical device in 2018, and...
